Clinical Trial Update: Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease

View source ↗

Summary

A completed clinical trial evaluating optimal antiplatelet therapy for Chinese patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Coronary Artery Disease | Status: COMPLETED